NEW YORK (Reuters) – New coronavirus cases are falling in parts of the United States hit hardest by the fast-spreading Omicron variant, according to a…
Номе
With Roe in Doubt, States Act on Abortion Limits, Expansions
SALT LAKE CITY (AP) — It didn’t take long for abortion to re-emerge as a flashpoint in state legislatures. Less than a month into the…
Current vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2 variants
Scientists at La Jolla Institute for Immunology (LJI) have found that four COVID-19 vaccines (Pfizer-BioNTech, Moderna, J&J/Janssen, and Novavax) prompt the body to make effective,…
Cataract surgery may cut dementia risk by nearly 30%, study finds
Cataract surgery may cut the risk of developing dementia by nearly 30%, study finds People who have cataract surgery 30% less likely to get dementia,…
Heat dome and other climate events have growing impact on mental health, study shows
Last summer’s Western North American heat dome caused more than record-breaking temperature increases—rising anxiety about climate change is reported in a new study on the…
How mRNA and DNA vaccines could soon treat cancers, HIV, autoimmune disorders and genetic diseases
The two most successful coronavirus vaccines developed in the U.S. – the Pfizer and Moderna vaccines—are both mRNA vaccines. The idea of using genetic material…
FDA may limit use of two COVID antibody treatments
The U.S. Food and Drug Administration may soon curtail the use of two monoclonal antibody treatments that do not appear to work against the highly…
How can Commensal Bacteria turn Harmful?
The switch from commensal to pathogenic is considered to be an important switch that has direct consequences on human health these can involve the acquisition…
New technology for efficient diagnosis of dizziness problems
Patients with dizziness problems can now get better diagnosis in a simple and painless way. A new type of bone conduction speaker, easily attached behind…
Dual Immunotherapy Promising New Option for Liver Cancer
SAN FRANCISCO ― A novel dual immunotherapy regimen significantly improved overall survival compared to a standard of care in patients with advanced, unresectable hepatocellular carcinoma…